Skip to main content

Corporate insider profile

Peter Blume-Jensen Insider Trades

Latest reported as President and CEO of Acrivon Therapeutics, Inc. (ACRV).

Purchase filings
0
Reported companies
1
Net open-market value
-$34,412.16
Latest transaction
Aug 25, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Aug 25, 2026Acrivon Therapeutics, Inc. (ACRV)President and CEOSale14,036$2.21$30,969
Aug 18, 2026Acrivon Therapeutics, Inc. (ACRV)President and CEOSale1,713$2.01$3,443